Skip to main content

Closed

PMN: ProMIS Neurosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-68.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio9.92×

ProMIS Neurosciences, Inc.

PMNNASDAQ Capital Market·USD·Closed

ProMIS Neurosciences, Inc.

PMNNASDAQ·USD·Closed

$13.72

−8.04%

$13.72

−$1.20 (8.04%)

52W Range

35thpctl

Volume

0.38×avg

Mkt Cap

17.94MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

35thpctl

Volume

0.38×avg

Market Cap

17.94MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings